Calladine D, Evans JR, Shah S, Leyland M. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD003169. DOI: 10.1002/14651858.CD003169.pub3. Link to Cochrane Library.
Leurs LJ et al. (2010) Relationship between tap water hardness, magnesium, and calcium concentration and mortality due to ischemic heart disease or stroke in the Netherlands. Environmental Health Perspectives, 118(3):414–420.
National Research Council (1977) Drinking water and health. Washington, DC, National Academy of Sciences.
Ong CN, Grandjean AC, Heaney RP (2009) The mineral composition of water and its contribution to calcium and magnesium intake. In: Calcium and magnesium in drinking-water: public health significance. Geneva, World Health Organization, pp. 36–58 (http://whqlibdoc.who.int/publications/2009/9789241563550_eng.pdf).
WHO (2009) Calcium and magnesium in drinking-water: public health significance. Geneva, World Health Organization (http://whqlibdoc.who.int/publications/2009/9789241563550_eng.pdf).
Sorensen MD, Eisner BH, Stone KL, et al. Impact of calcium intake and intestinal calcium absorption on kidney stones in older women: the study of osteoporotic fractures. J Urol 2012;187:1287-92. [PMC free article] [PubMed] [Google Scholar]
Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992;327:1141-52.
Sorensen MD, Duh QY, Grogan RH, et al. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism. Surgery 2012;151:477-83.
Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med 2010;363:954-63. [PMC free article] [PubMed] [Google Scholar]
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8. [PubMed] [Google Scholar]
Sorensen MD, Kahn AJ, Reiner AP, et al. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol 2012;187:1645-9. [PMC free article] [PubMed] [Google Scholar]
Hess B, Jost C, Zipperle L, et al. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 1998;13:2241-7. [PubMed] [Google Scholar]
Bataille P, Charransol G, Gregoire I, et al. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol 1983;130:218-23. [PubMed] [Google Scholar]
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84. [PubMed] [Google Scholar]
Wallace RB, Wactawski-Wende J, O’Sullivan MJ, et al. Urinary tract stone occurrence in the Women’s Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 2011;94:270-7. [PMC free article] [PubMed] [Google Scholar]
Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 2004;15:3225-32. [PubMed] [Google Scholar]
3. ถามว่าเป็นหัวใจเต้นรัวแบบ AF แต่จะไม่กินยากันเลือดแข็ง จะไปกินวิตามินอี.หรือน้ำมันปลาแทนได้ไหม ตอบว่าไม่ได้ครับ ยากันเลือดแข็งมีหลักฐานข้อมูลว่าลดโอกาสเกิดหลอดเลือดอุดตันในผู้ป่วย AF ได้ แต่วิตามินอี.และน้ำมันปลาไม่มีหลักฐานแม้แต่ชิ้นเดียวว่ามันลดโอกาสเกิดหลอดเลือดอุดตันใน AF จนใช้แทนยากันเลือดแข็งได้ ดังนั้นจึงใช้แทนกันไม่ได้
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J et.al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2009; 361:1139-1151
European Society of Cardiology. 2012 Update of the ESC Guidelines on the management of atrial fibrillation. European Heart Journal 2012. DOI:10.1093/Eurheartj.ehs25
Tomimori H, Yamamura N, Adachi T, Fukui K. Pharmacokinetics, safety and pharmacodynamics after multiple oral doses of dabigatran etexilate capsule (110 mg and 150 mg b.i.d., 7 days) in healthy Japanese and Caucasian male subjects: An open label study. Study no. 1160.61. Report no. U06-3420. Boehringer Ingelheim Internal Report, 2006.
Pollack CV-Jr., Reilly PA et al. Idarucizumab for Dabigatran Reversal — Full Cohort Analysis. N Engl J Med 2017; 377:431-441August 3, 2017DOI: 10.1056/NEJMoa1707278
Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257–e354.
Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, Boucher R, Greene T, Beddhu S. The Associations of Plant Protein Intake With All-Cause Mortality in CKD. Am J Kidney Dis. 2016 Mar;67(3):423-30. doi: 10.1053/j.ajkd.2015.10.018.
Kim J, Ahn CW, Fang S, Lee HS, and Park JS. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore). 2019 Nov; 98(46): e17918. Published online 2019 Nov 15. doi: 10.1097/MD.0000000000017918
Andrew B. Crouse, Tiffany Grimes, Peng Li, Matthew Might, Fernando Ovalle, Anath Shalev. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes. Frontiers in Endocrinology, 2021; 11 DOI: 10.3389/fendo.2020.600439
Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017 Jan. 92 (1):94-108.
Lee HS, Park LC, Lee EM, Lee SJ, Shin SH, Im H, et al. Incidence Rates and Risk Factors for Vascular Events in Patients With Essential Thrombocythemia: A Multicenter Study From Korea. Clin Lymphoma Myeloma Leuk. 2011 Nov 14.
Shrestha R, Giri S, Pathak R, Bhatt VR. Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia. World J Clin Oncol. 2016 Aug 10. 7 (4):324-30.
Yogarajah M, Tefferi A. Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and Outcome. Mayo Clin Proc. 2017 Jul. 92 (7):1118-1128.
Tefferi A, Fonseca R, Pereira DL, Hoagland HC. A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc. 2001 Jan. 76(1):22-8.
Godfrey AL, Campbell PJ, MacLean C, et al. Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features. J Clin Oncol. 2018 Aug 28. JCO2018788414.